ID: ALA4210951

Max Phase: Preclinical

Molecular Formula: C5H8N2O2

Molecular Weight: 128.13

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CNC(=O)NC(C)=O

Standard InChI:  InChI=1S/C5H8N2O2/c1-3-6-5(9)7-4(2)8/h3H,1H2,2H3,(H2,6,7,8,9)

Standard InChI Key:  SLFPOAYQUGZUGY-UHFFFAOYSA-N

Associated Targets(non-human)

Major prion protein 73 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 128.13Molecular Weight (Monoisotopic): 128.0586AlogP: -0.02#Rotatable Bonds: 1
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.68CX Basic pKa: CX LogP: -0.65CX LogD: -0.65
Aromatic Rings: 0Heavy Atoms: 9QED Weighted: 0.52Np Likeness Score: -0.38

References

1. Pagadala NS, Bjorndahl TC, Joyce M, Wishart DS, Syed K, Landi A..  (2017)  The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrPC to PrPSc with lower IC50 in ScN2a cells.,  25  (20): [PMID:28951092] [10.1016/j.bmc.2017.09.024]

Source